Other Clinical Trial - Ovarian Reserve After Ovarian Hemostasis by Floseal

Status Completed

Clinical Trial Summary

Laparoscopy has become the gold standard for the surgical treatment of benign ovarian cysts and is usually performed by stripping the ovarian cyst wall, followed by bleeding control of the ovarian wound ground using bipolar coagulation. However, the hemostasis with bipolar coagulation could result in the damage of ovarian reserve and decrease the response of the ovaries to hormonal stimulation for assisted reproductive technologies. The possible mechanism may contribute to thermal destruction of ovarian follicles by excessive use of bipolar coagulation for hemostasis purposes.

To avoid additional ovarian tissue damage by conventional bipolar coagulation being potentially important ovarian reproductive function, hemostasis using various topical hemostatic agents has introduced to control post-cystectomy ovarian wound bleeding. Among them, FloSeal (Baxter Healthcare Corporation, Deerfield, IL, USA) is a hemostatic matrix sealant composed of a gelatin-based matrix and thrombin solution. On coming into contact with blood after application at a bleeding site, the gelatin particles swell and tamponade bleeding. The bulk of the gelatin matrix-thrombin composite has the effect of slowing blood flow and providing exposure to a high thrombin concentration, thus hastening clot formation. Therefore, it may more suitable for use in post-cystectomy ovarian wound bleeding, where there is superficially pervasive focus of bleeding.

Ovarian reserve is defined as the functional potential of the ovary, which reflects the number and quality of antral follicles left in the ovary, and is correlated with the response to ovarian stimulation using exogenous gonadotropin. Serum anti-Müllerian hormone (AMH) has been accepted as the most reliable and easily measurable marker for postoperative assessment of ovarian reserve.

The investigators conducted a multicenter, large-scale, randomized controlled trial to investigate whether hemostasis by Floseal was superior to that by bipolar coagulation in preserving ovarian reserve by assessing serial AMH levels in patients undergoing laparoscopic ovarian cystectomy for benign ovarian cysts.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Ovarian Cysts

Clinical Trial Details

NCT number	NCT01857466
Study type	Interventional
Source	CHA University
Contact
Status	Completed
Phase	Phase 3
Start date	December 2012
Completion date	October 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02890914` - Transvaginal Ultrasound Training for Obstetrics and Gynecology Residents	N/A
Completed	`NCT01779232` - Danazol Treatment in Endometriosis Women Before IVF	Phase 4
Completed	`NCT05054946` - The Effect of Laparoscopic Surgery on Ovarian Reserve According to Cyst Types	N/A
Completed	`NCT02852447` - The Effect of Surgery for Non Endometriosic Ovarian Cysts on Ovarian Reserve	N/A
Completed	`NCT00713778` - The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cyst	Phase 4
Suspended	`NCT00865488` - Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery	Phase 3
Completed	`NCT04142203` - Implementation of 23 Hour Surgery Model in a Tertiary Hospital
Recruiting	`NCT05842629` - Improved Diagnosis of Ovarian Cancer
Completed	`NCT05376384` - Ovarian Cyst's Enucleation Spillage Score
Recruiting	`NCT04993924` - GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst	Phase 4
Terminated	`NCT03189316` - Anti-inflammatory Cells in Peritoneal Cavity	N/A
Completed	`NCT05800613` - Management of Ovarian Masses in Pediatric Patients: an Italian Survey
Completed	`NCT04355312` - Using INDOcyanine Green to Analyse Ovarian Vascularization After Ovarian Laparoscopic CYStectomy	N/A
Completed	`NCT05418595` - Ultrasonographic Evaluation of Ovarian Stromal Vascularity in Women With Polycystic Ovary Syndrome (PCOS)
Completed	`NCT06342934` - Radiomics and Machine Learning in the Diagnosis of Ovarian Masses
Completed	`NCT06227676` - Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25	Phase 2/Phase 3
Completed	`NCT02831556` - Point of Care 3D Ultrasound for Various Applications: A Pilot Study
Recruiting	`NCT05763511` - Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker
Completed	`NCT06064331` - Effect of Intravenous Lignocaine Infusion on Intraoperative End Tidal Desflurane Concentration Requirements	N/A
Recruiting	`NCT02086318` - A New Algorithm to Predict Ovarian Age	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Ovarian Reserve After Ovarian Hemostasis by Floseal Matrix

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms